ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,123, issued on Dec. 2, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"1 H -pyrazolo[4,3- d pyrimidine compounds as toll-like receptor 7 (TLR7) agonists" was invented by Qian Zhang (Danville, Calif.), Sanjeev Gangwar (Foster City, Calif.), Ashvinikumar V. Gavai (Princeton Junction, N.J.), Qiang Cong (Palo Alto, Calif.), Yam B. Poudel (Fremont, Calif.), Liqi He (San Jose, Calif.), Prasanna Sivaprakasam (Plainsboro, N.J.) and Christine M. Tarby (Lawrenceville, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds according to formula I are useful as agonists of Toll-like receptor 7 (TLR7). Such compounds can be used in cancer treat...